Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Influenza pandemics--pregnancy, pathogenesis, and perinatal outcomes.

Steinhoff MC, MacDonald NE.

JAMA. 2012 Jul 11;308(2):184-5. doi: 10.1001/jama.2012.7911. No abstract available. Erratum in: JAMA. 2012 Oct 3;308(13):1324.

PMID:
22782421
2.

H1N1 influenza vaccination during pregnancy.

Fell DB, Dodds L, McNeil S, MacDonald NE.

BMJ. 2014 May 29;348:g3500. doi: 10.1136/bmj.g3500. No abstract available.

PMID:
24874846
3.

Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A.

JAMA. 2012 Jul 11;308(2):165-74. doi: 10.1001/jama.2012.6131.

PMID:
22782418
4.

Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study.

Trotta F, Da Cas R, Spila Alegiani S, Gramegna M, Venegoni M, Zocchetti C, Traversa G.

BMJ. 2014 May 29;348:g3361. doi: 10.1136/bmj.g3361.

5.

Pandemic vaccines and small excess of Guillain-Barre cases.

[No authors listed]

BMJ. 2013 Mar 20;346:f1714. doi: 10.1136/bmj.f1714. No abstract available.

PMID:
23516147
6.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group..

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
7.

Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth.

Ahrens KA, Louik C, Kerr S, Mitchell AA, Werler MM.

Paediatr Perinat Epidemiol. 2014 Nov;28(6):498-509. doi: 10.1111/ppe.12152. Epub 2014 Oct 21.

8.

Influenza vaccine and Guillain-Barré syndrome: making informed decisions.

Poland GA, Poland CM, Howe CL.

Lancet. 2013 Apr 27;381(9876):1437-9. doi: 10.1016/S0140-6736(13)60182-8. No abstract available.

PMID:
23622271
9.

Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines.

DeStefano F, Vellozzi C, Schonberger LB, Chen RT.

BMJ. 2011 Jul 12;343:d4159. doi: 10.1136/bmj.d4159. No abstract available.

PMID:
21750073
10.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689
11.
12.

Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.

Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, Miller E.

Lancet. 2011 Oct 29;378(9802):1545-6. doi: 10.1016/S0140-6736(11)61665-6. No abstract available.

PMID:
22035553
13.

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Håberg SE.

Eur J Epidemiol. 2016 Jan;31(1):67-72. doi: 10.1007/s10654-015-0047-0. Epub 2015 May 26.

PMID:
26008750
14.

The self-controlled case series method for evaluating safety of vaccines.

Hawken S, Wilson KR.

Med J Aust. 2012 Nov 19;197(10):578-9.

PMID:
23163690
15.

Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.

Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.

Vaccine. 2015 Apr 8;33(15):1815-23. doi: 10.1016/j.vaccine.2015.02.035. Epub 2015 Feb 26.

PMID:
25728315
16.

[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].

Press R, Andersen O.

Lakartidningen. 2010 Mar 10-16;107(10):666-7. Swedish. No abstract available.

PMID:
20402249
17.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.

18.

Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.

Jones TF, McMillian M, Boothe E, Hanna S, Ingram LA.

Emerg Infect Dis. 2010 Sep;16(9):1500-1. doi: 10.3201/eid1609.091837. No abstract available.

19.

The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.

Tokars JI, Lewis P, DeStefano F, Wise M, Viray M, Morgan O, Gargiullo P, Vellozzi C.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):546-52. doi: 10.1002/pds.3220. Epub 2012 Mar 8.

PMID:
22407672
20.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419

Supplemental Content

Support Center